Acquisition of Mariana Oncology brings together two companies at the forefront of novel radiopharmaceutical development, with a total potential value of up to $1.75 billion
News | Radiation Oncology
Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
Home
Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients receiving care at accredited cancer hospitals in Pennsylvania
News | Radiation Oncology
Affordable Care Act Expansions Improved Access to Cancer Care, Study Suggests

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients ...

Time May 10, 2024
Home
Justin Hernandez, MD
News | ARRS
Race, Gender and Risk of Not Matching In Diagnostic Radiology

May 8, 2024 — Compared to males, women in radiology are at a consistently higher risk of not matching into diagnostic ...

Time May 08, 2024
Home
POSLUMA (flotufolastat F 18) PET/CT image showing uptake in the prostate gland, consistent with primary prostate cancer.
News | Radiopharmaceuticals and Tracers
Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA (Flotufolastat F 18) Clinical Data to Support AI-based Algorithms Development

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
Home
Swedish biotech company Ascelia Pharma has announced its liver imaging drug candidate, Orviglance, significantly improved visualization of focal liver lesions, having successfully met the primary endpoint in the pivotal Phase 3 study, SPARKLE. CEO Magnus Corftizen shown here, offered an update on the first-in-class contrast agent for use in liver MRI in patients with severely impaired kidney function which has been granted FDA Orphan Drug Designation.
News | Contrast Media
Ascelia Pharma Meets Primary Endpoint in Phase 3 Study of Orviglance Liver Imaging Contrast Agent Drug Candidate

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
Home
The Radiological Society of North America (RSNA) and the Radiological and Diagnostic Imaging Society of São Paulo (SPR) have agreed to continue their partnership
News | RSNA
RSNA, SPR Partner for JPR Meetings in São Paulo, Brazil

May 7, 2024 — The Radiological Society of North America (RSNA) and the Radiological and Diagnostic Imaging Society of ...

Time May 07, 2024
Home
66-year-old female with severe shoulder pain
News | Magnetic Resonance Imaging (MRI)
ARRS Annual Meeting: Accessory Infraglenoid Muscle With, Without Teres Minor Fatty Infiltration on Shoulder MRI

May 7, 2024 — The Magna Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting showed a ...

Time May 07, 2024
Home
The American Roentgen Ray Society (ARRS) announced that Philip Costello, MD, the 118th ARRS President and recently named chair of The Roentgen Fund Board of Trustees, has been awarded the 2024 ARRS Gold Medal
News | ARRS
American Roentgen Ray Society Awards 2024 ARRS Gold Medal to Former President, Present Roentgen Fund Chair, Philip Costello

May 7, 2024 — The American Roentgen Ray Society (ARRS) announced that Philip Costello, MD, the 118th ARRS President and ...

Time May 07, 2024
Home
ScreenPoint Medical’s Board of Directors has announced the appointment of Peter Kroese as the new Chief Executive Officer (CEO) of the breast artificial intelligence (AI) company. Kroese served as the company COO for over five years.
News | Radiology Business
ScreenPoint Medical Appoints Pieter Kroese from COO to CEO Role at Breast AI Company

May 6, 2024 — ScreenPoint Medical’s Board of Directors has announced the appointment of Peter Kroese as the new Chief ...

Time May 06, 2024
Home
GE HealthCare has announced the unveiling of its SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience.
News | Magnetic Resonance Imaging (MRI)
GE Healthcare Unveils Head-only MR Scanner Toward Neuroscience Advancements 

May 6, 2024 — GE HealthCare has announced the unveiling of its SIGNA MAGNUS[i], an FDA 510(k) pending head-only magnetic ...

Time May 06, 2024
Home
Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent portfolio
News | Treatment Planning
Elekta Further Strengthens its Elekta ONE Software Suite with Acquisition of Philips Treatment Planning Patent Portfolio

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
Home
The MRI sensor or magnetometer uses laserlight and gas to measure magnetic fields.
News | Magnetic Resonance Imaging (MRI)
Young Researcher has Created a Sensor that Detects Errors in MRI Scans

May 6, 2024 — Hvidovre Hospital has the world's first prototype of a sensor capable of detecting errors in MRI scans ...

Time May 06, 2024
Home
The future of Mammography: 4 critical challenges
News | Mammography
Enable Me Cites New Research by Siemens Healthineers Concluding Job-Related Physical Stresses and Strains for Radiologists Are Resulting in More Turnover and Fewer Entering the Profession

May 6, 2024 — Enable Me, a VELA Medical company, cited major new research by Siemens Healthineers entitled, “The future ...

Time May 06, 2024
Home
Carestream DRX-Evolution Plus System
Feature | Digital Radiography (DR) | By Melinda Taschetta-Millane
The Top 10 Trends in Digital Radiography

Digital radiography (DR) continues to advance at a rapid pace with today’s technological innovations and evolving ...

Time May 06, 2024
Home
A look at ITN's top-viewed content for April 2024
Feature | Radiology Business | By Melinda Taschetta-Millane
Top 10: What Viewers Were Reading in April

One on One interviews with radiology trailblazers and historic FDA clearances made the top-read list for April. Take a ...

Time May 03, 2024
Home
Ultrasound offers a supplemental scan and peace of mind in its ability to find the pathology and almost instantaneously distinguishes a benign cyst from a possible or definite cancer
Feature | Breast Density | By Robert L. Bard, MD
Pathological Views of Dense Breast Tissue

Decades since the advent of breast scanning technology, innovations in noninvasive diagnostic imaging provide new ...

Time May 03, 2024
Home
Advances in the growing radiation dose management market are continually helping those who administer treatment to focus on personalized patient care and workflow management
Feature | Radiation Dose Management | By Christine Book
Radiation Dose Management Market Overview and Product Updates

Advances in the growing radiation dose management market are continually helping those who administer treatment to focus ...

Time May 03, 2024
Home
A new study from Mass General Brigham has found that large foundation models that incorporate a richer level of details may mitigate disparities between different demographic groups and enhance model security.
News | Artificial Intelligence
Mass General Brigham Researchers Reduce Bias on Pathology AI Algorithms Using Foundation Models, Report Results Serve as ‘Call to Action’ to Improve Equity

May 2, 2024 — A new study from Mass General Brigham has found that large foundation models that incorporate a richer ...

Time May 02, 2024
Home
At the upcoming European Society for Therapeutic Radiology and Oncology (ESTRO) 2024 Congress, GE HealthCare will be unveiling innovations which harness the power of AI to increase imaging accuracy and optimize the complex radiation therapy workflow across the cancer care continuum.
News | Radiology Business
GE HealthCare to Unveil AI-enhanced Oncology Solutions at ESTRO 2024 Congress

May 2, 2024 — GE HealthCare has announced a new radiation therapy computed tomography (CT) solution with innovative ...

Time May 02, 2024
Home
This acquisition signifies Radformation’s commitment to driving innovation and expanding its AI-driven capabilities in cancer care.
News | Artificial Intelligence
Radformation to Accelerate AI-Based Solutions with Limbus AI Acquisition

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now